University of Pittsburgh Health Sciences eLearning Environment Internet-based Studies in Education and Research
INTRODUCTION
ABIM MOC Activity ID
12/3/24 - Medical Grand Rounds: The Art of Uncertainty: Tackling Gray Zones in Medicine - Pulmonary Embolism (PE)
QUIZ
EVALUATION
CERTIFICATE
Credit Hours: CME 1.00
Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.
Upon completion of this activity, participants should be able to:
- Describe the key factors used in the initial risk assessment of patients with pulmonary embolism, including the importance of hemodynamic stability and right ventricular dysfunction.
- Explain the role of systemic thrombolysis in the management of high-risk and intermediate/high-risk pulmonary embolism, including patient selection criteria and contraindications.
- Apply risk stratification tools, such as the Pulmonary Embolism Severity Index (PESI) and assessment of biomarkers (e.g., troponins), in determining the prognosis and management of patients with intermediate/high-risk pulmonary embolism.
Suggested Additional Reading:
- Konstantinides, SV, Meyer, G, Becattini, C, Bueno, et al. (2020). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). European Heart Journal, 41(4), 543–603. https://doi.org/10.1093/eurheartj/ehz405
- Meyer G, Vicaut E, Danays T, et al; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014 Apr 10;370(15):1402-11. doi: 10.1056/NEJMoa1302097. PMID: 24716681.
- Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest. 2021 Dec;160(6):e545-e608. doi: 10.1016/j.chest.2021.07.055. Epub 2021 Aug 2. Erratum in: Chest. 2022 Jul;162(1):269. doi: 10.1016/j.chest.2022.05.028. PMID: 34352278.
Joint Accreditation Statement
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™.Each physician should only claim credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
No relationships with industry relevant to the content of this educational activity have been disclosed.
No relationships with industry relevant to the content of this educational activity have been disclosed.
Dr Toma receives grant/research support and is a consultant for Neptune Medical.
No relationships with industry relevant to the content of this educational activity have been disclosed.
No relationships with industry relevant to the content of this educational activity have been disclosed.
This activity is approved for AMA PRA Category 1 Credit™
The University of Pittsburgh is an affirmative action, equal opportunity institution.